Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III Sells 1,257 Shares of Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III sold 1,257 shares of the business’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $59.26, for a total value of $74,489.82. Following the sale, the chief financial officer now directly owns 21,358 shares of the company’s stock, valued at approximately $1,265,675.08. This trade represents a 5.56 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Kewaunee Scientific Price Performance

KEQU stock opened at $55.20 on Tuesday. The stock has a 50-day moving average price of $48.78 and a two-hundred day moving average price of $45.11. Kewaunee Scientific Co. has a 12-month low of $27.00 and a 12-month high of $67.20. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48. The company has a market cap of $158.53 million, a PE ratio of 8.75 and a beta of 0.72.

Institutional Investors Weigh In On Kewaunee Scientific

Several institutional investors and hedge funds have recently modified their holdings of KEQU. JPMorgan Chase & Co. grew its stake in shares of Kewaunee Scientific by 18,000.0% in the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after buying an additional 900 shares in the last quarter. Barclays PLC acquired a new stake in shares of Kewaunee Scientific in the third quarter valued at about $121,000. Heron Bay Capital Management acquired a new stake in shares of Kewaunee Scientific in the second quarter valued at about $252,000. State Street Corp acquired a new stake in shares of Kewaunee Scientific in the third quarter valued at about $266,000. Finally, Ritholtz Wealth Management grew its stake in shares of Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after buying an additional 2,156 shares in the last quarter. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, December 18th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.